Tony Serafini-Lamanna - 15 Nov 2021 Form 4 Insider Report for MERIDIAN BIOSCIENCE INC

Role: Executive VP-Diagnostics
Signature: /s/ Bryan T. Baldasare as Attorney-in-fact for Tony Serafini-Lamanna
Issuer symbol: N/A
Transactions as of: 15 Nov 2021
Net transactions value: $0
Form type: 4
Filing time: 16 Nov 2021, 14:59:44 UTC
Previous filing: 08 Nov 2021
Next filing: 05 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VIVO	Common Stock	Other		-24,343	-57%		18,093	15 Nov 2021	Direct	F1
transaction	VIVO	Common Stock	Award		+24,343	+135%		42,436	15 Nov 2021	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted share units granted pursuant to 2012 Stock Incentive Plan rescinded by the Issuer.
F2	Restricted share units granted pursuant to 2021 Omnibus Award Plan scheduled to vest as follows: (i) 1,200 on September 16, 2022; (ii) 12,320 on November 15, 2022; and (iii) 10,823 on November 15, 2023.